Production facility

The RNA Platform NZ production facility offers research-grade RNA and lipid nanoparticle (LNP) formulation services at highly competitive rates. Our services provide researchers with a reliable and accessible way to test RNA delivery and expression in systems of interest.

Reporter RNAs are ideal for validating cellular uptake, tracking expression, and optimising delivery technologies.

RNA technology

Check out the video made by our technology partner, the Malaghan Institute of Medical Research, to discover the benefits of RNA technology for New Zealand.

Contact

Email us for any inquries include quotes for services we provide.

Services we provide

mRNA production service

Our RNA is produced in New Zealand, reducing shipping costs and turnaround time for local researchers.

All RNA is manufactured to industry standards and characterised for:

  • high RNA integrity
  • low double-stranded RNA (dsRNA) content
  • high capping efficiency
  • low endotoxin levels.

These high-quality RNAs are suitable for a wide range of in vitro and in vivo research applications.

Back to top ^

LNP formulation service

In addition to RNA production, we provide lipid nanoparticle (LNP) formulation services using either industry-standard ionisable lipids or proprietary/client-supplied lipids.

Whether you are testing uptake in vitro or preparing for in vivo delivery studies, we can formulate LNPs tailored to your experimental needs.

LNPs are produced using microfluidic mixing and characterised to ensure:

  • small particle sizes
  • low polydispersity index (PDI)
  • high encapsulation efficiency.

These formulations are well-suited for proof-of-concept studies, delivery optimisation, and early-stage preclinical research.

We also welcome discussions around custom RNA production and formulation tailored to specific research requirements.

Back to top ^

Off-the-shelf products

We maintain a catalogue of commonly used mRNAs that serve as reliable experimental controls, including reporter constructs, model antigens, and genome-editing RNAs.

These products are available for immediate shipment.

Available mRNAs include:

  • GFP
  • Luciferase
  • OVA
  • HA
  • Cas9
  • FL-Spike.

Back to top ^

GMP manufacturing

The RNA Platform is partnering with South Pacific Sera, a GMP manufacturer with capabilities in:

  • cell culture
  • sterile filtration
  • protein purification
  • vial filling
  • freeze drying.

The founder of South Pacific Sera, Dr William Rolleston, leads the Platform’s Manufacturing Pillar. His team is working closely with the RNA Platform production team to establish scalable methodologies for:

  • DNA template production
  • in vitro transcription (IVT)
  • RNA manufacturing
  • LNP encapsulation
  • quality control.

For enquiries regarding GMP manufacturing of RNA products, please contact Dr William Rolleston for further details.

Back to top ^